合計 50 件の最近のインサイダー取引記録が記録されています Mind Medicine (MindMed) Inc. (MNMD), 内訳は 26 件の買い および 22 件の売り. インサイダー買い総額は $14.47M インサイダー売り総額は $1.75M.
最近活動のある主要インサイダーには Sullivan Mark, Barrow Robert, Karlin Daniel. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — MNMD
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-06-25 |
Sullivan Mark |
Chief Legal Officer |
情報に基づく売り |
11,491 |
$6.80 |
$78.14K |
305,130 |
| 2025-06-25 |
Barrow Robert |
Chief Executive Officer |
情報に基づく売り |
26,491 |
$6.80 |
$180.14K |
830,065 |
| 2025-06-25 |
Karlin Daniel |
Chief Medical Officer |
情報に基づく売り |
7,848 |
$6.80 |
$53.37K |
438,329 |
| 2025-06-12 |
Gryska David W |
Director |
RSU 付与（制限付株式） |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-12 |
Vallone Carol A |
Director |
RSU 付与（制限付株式） |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-12 |
Krebs Andreas |
Director |
RSU 付与（制限付株式） |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-12 |
Bruhn Suzanne Louise |
Director |
RSU 付与（制限付株式） |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-12 |
Crystal Roger |
Director |
RSU 付与（制限付株式） |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-02 |
Roberts Brandi |
Officer |
不明 |
- |
- |
- |
- |
| 2025-06-02 |
Roberts Brandi |
Chief Financial Officer |
RSU 付与（制限付株式） |
500,000 |
$7.26 |
$3.63M |
500,000 |
| 2025-03-25 |
Sullivan Mark |
Chief Legal Officer |
情報に基づく売り |
6,576 |
$6.74 |
$44.32K |
316,621 |
| 2025-03-25 |
Barrow Robert |
Chief Executive Officer |
情報に基づく売り |
21,208 |
$6.74 |
$142.94K |
856,556 |
| 2025-03-25 |
Karlin Daniel |
Chief Medical Officer |
情報に基づく売り |
6,836 |
$6.74 |
$46.07K |
446,177 |
| 2025-03-25 |
Liao Carrie |
Chief Accounting Officer |
情報に基づく売り |
2,347 |
$6.74 |
$15.82K |
144,923 |
| 2025-03-17 |
Wiley Matthew T. |
Officer |
不明 |
- |
- |
- |
- |
| 2025-03-17 |
Wiley Matthew T. |
Chief Commercial Officer |
RSU 付与（制限付株式） |
350,000 |
$6.35 |
$2.22M |
350,000 |
| 2025-03-12 |
Sullivan Mark |
Chief Legal Officer |
RSU 付与（制限付株式） |
150,000 |
- |
- |
323,197 |
| 2025-03-12 |
Barrow Robert |
Chief Executive Officer |
RSU 付与（制限付株式） |
350,000 |
- |
- |
877,764 |
| 2025-03-12 |
Karlin Daniel |
Chief Medical Officer |
RSU 付与（制限付株式） |
115,000 |
- |
- |
453,013 |
| 2025-03-12 |
Liao Carrie |
Chief Accounting Officer |
RSU 付与（制限付株式） |
50,000 |
- |
- |
142,270 |
| 2024-12-26 |
Sullivan Mark |
Chief Legal Officer |
情報に基づく売り |
4,519 |
$7.43 |
$33.58K |
173,197 |
| 2024-12-26 |
Barrow Robert |
Chief Executive Officer |
情報に基づく売り |
19,106 |
$7.43 |
$141.96K |
526,666 |
| 2024-12-26 |
Karlin Dan |
Chief Medical Officer |
情報に基づく売り |
6,643 |
$7.43 |
$49.36K |
338,013 |
| 2024-12-26 |
Liao Carrie |
Chief Accounting Officer |
情報に基づく売り |
2,273 |
$7.43 |
$16.89K |
97,270 |
| 2024-12-05 |
Gryska David W |
Director |
情報に基づく買い |
2,500 |
$7.17 |
$17.93K |
19,851 |
| 2024-09-25 |
Sullivan Mark |
Chief Legal Officer |
情報に基づく売り |
4,430 |
$5.98 |
$26.49K |
177,716 |
| 2024-09-25 |
Barrow Robert |
Chief Executive Officer |
情報に基づく売り |
19,771 |
$5.98 |
$118.23K |
545,772 |
| 2024-09-25 |
Karlin Dan |
Chief Medical Officer |
情報に基づく売り |
6,871 |
$5.98 |
$41.09K |
344,656 |
| 2024-09-25 |
Liao Carrie |
Chief Accounting Officer |
情報に基づく売り |
2,352 |
$5.98 |
$14.06K |
99,543 |
| 2024-08-23 |
Gryska David W |
Director |
情報に基づく買い |
3,500 |
$5.98 |
$20.93K |
17,351 |
| 2024-08-21 |
Halperin Wernli Miri |
Executive President |
オプション行使（売却） |
50,000 |
$3.70 |
$185K |
- |
| 2024-08-20 |
Barrow Robert |
Chief Executive Officer |
情報に基づく買い |
500 |
$6.12 |
$3.06K |
565,543 |
| 2024-08-19 |
Barrow Robert |
Chief Executive Officer |
情報に基づく買い |
500 |
$6.31 |
$3.16K |
565,043 |
| 2024-06-25 |
Sullivan Mark |
Chief Legal Officer |
情報に基づく売り |
17,854 |
$7.22 |
$128.91K |
182,146 |
| 2024-06-25 |
Barrow Robert |
Chief Executive Officer |
情報に基づく売り |
15,659 |
$7.22 |
$113.06K |
564,543 |
| 2024-06-25 |
Karlin Dan |
Chief Medical Officer |
情報に基づく売り |
6,925 |
$7.22 |
$50K |
351,527 |
| 2024-06-10 |
Gryska David W |
Director |
RSU 付与（制限付株式） |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-06-10 |
Vallone Carol A |
Director |
RSU 付与（制限付株式） |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-06-10 |
Krebs Andreas |
Director |
RSU 付与（制限付株式） |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-06-10 |
Bruhn Suzanne Louise |
Director |
RSU 付与（制限付株式） |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-06-10 |
Crystal Roger |
Director |
RSU 付与（制限付株式） |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-03-25 |
Greenway Schond L. |
Chief Financial Officer |
RSU 源泉徴収 |
5,560 |
$9.78 |
$54.38K |
211,057 |
| 2024-03-25 |
Barrow Robert |
Chief Executive Officer |
情報に基づく売り |
16,519 |
$9.50 |
$156.93K |
580,202 |
| 2024-03-25 |
Karlin Dan |
Chief Medical Officer |
情報に基づく売り |
6,578 |
$9.50 |
$62.49K |
358,452 |
| 2024-02-27 |
Sullivan Mark |
Chief Legal Officer |
RSU 付与（制限付株式） |
125,000 |
$4.98 |
$622.5K |
125,000 |
| 2024-02-27 |
Greenway Schond L. |
Chief Financial Officer |
RSU 付与（制限付株式） |
150,000 |
$4.98 |
$747K |
150,000 |
| 2024-02-27 |
Barrow Robert |
Chief Executive Officer |
RSU 付与（制限付株式） |
400,000 |
$4.98 |
$1.99M |
400,000 |
| 2024-02-27 |
Wernli Miri Halperin |
Executive President |
RSU 付与（制限付株式） |
125,000 |
$4.98 |
$622.5K |
125,000 |
| 2024-02-27 |
Karlin Dan |
Chief Medical Officer |
RSU 付与（制限付株式） |
150,000 |
$4.98 |
$747K |
150,000 |
| 2024-02-27 |
Liao Carrie |
Chief Accounting Officer |
RSU 付与（制限付株式） |
100,000 |
$4.98 |
$498K |
100,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
